Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Aortic Valve Stenosis Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

26 recruiting trials for Aortic Valve Stenosis. Eligibility criteria explained in plain English.

TrialFinderData lists 26 Aortic Valve Stenosis clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Every phased trial in this set is Phase 3 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.

Research is led by Edwards Lifesciences (2), Niguarda Hospital (2), Massachusetts General Hospital (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Transcatheter Aortic Valve Implantation (device, 2 trials), followed by Aortic valve replacement, 11C-Martinostat.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
26
Total Trials
26
Recruiting Now
1
Phase 3 Trials
10
Sponsors

Track Aortic Valve Stenosis trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT03549559

Imaging Histone Deacetylase in the Heart

The overall goal of this PET-MR imaging trial is to evaluate 11C-Martinostat, a histone deacetylase targeted radioligand, in patients with aortic stenosis, individuals with...

Sponsor: Massachusetts General HospitalEnrolling: 961 location
RECRUITINGNCT07205341

Detecting Changes in Arterial Blood Volume and Cardiac Efficiency

The objective of this Pilot Study is to demonstrate the efficacy of the Hemocept device in detecting changes in arterial blood volume and cardiac efficiency.

Sponsor: HemoCept Inc.Enrolling: 201 location
RECRUITINGNCT04414865

VitaFlow™ Transcatheter Aortic Valve System Post-market Study-The LAUNCH Study

The study objective is to evaluate safety and effectiveness/performance of the Microport™ CardioFlow VitaFlow™ Transcatheter Aortic Valve System for the treatment of severe aortic...

Sponsor: Shanghai MicroPort CardioFlow Medtech Co., Ltd.Enrolling: 1002 locations
RECRUITINGNCT05172973

ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic...

The objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4 Transcatheter Heart Valve (THV) in subjects who are at high or greater risk with...

Sponsor: Edwards LifesciencesEnrolling: 20020 locations
RECRUITINGNCT07284550

Smartphone Based Digital Screening for Aortic Valve Stenosis

Heart valve diseases are among the most serious cardiovascular conditions in older age. One of the most common forms is aortic valve stenosis, a narrowing of the valve opening...

Sponsor: Medical University InnsbruckEnrolling: 5001 location
RECRUITINGNCT03192774

The Prospective Segeberg TAVI Registry

A single center registry including all patients treated with TAVI at the Heart Center, Bad Segeberg, Germany

Sponsor: Segeberger Kliniken GmbHEnrolling: 20001 location
RECRUITINGNCT05015452

The Leipzig TAVI Registry

A single-center registry including all patients treated with TAVI at the Heart Center, Leipzig, Germany

Sponsor: Helios Health Institute GmbHEnrolling: 200001 location
RECRUITINGNCT04227002

Hamburg AoRtic Valve cOhoRt

The primary aim of the study is to identify the optimal treatment modality for patients with aortic valve disease, incorporating the individual patient's risk profile and...

Sponsor: Universitätsklinikum Hamburg-EppendorfEnrolling: 150001 location
RECRUITINGNCT05711186

Structured Shared Decision Making for Patients Undergoing SAVR or TAVR

Transcatheter aortic valve replacement (TAVR) is a well-established alternative to surgical aortic valve replacement (SAVR) for the treatment of patients with severe aortic...

Sponsor: Insel Gruppe AG, University Hospital BernEnrolling: 1401 location
RECRUITINGNCT06493994

Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry

Study goal is to determine the feasibility, procedural success, safety and potential benefit of the Myval transcatheter heart valve (THV) in patients undergone transaxillary (TAX)...

Sponsor: University of LuebeckEnrolling: 1001 location
RECRUITINGNCT06000943

Ischemic And Bleeding Risk Assessment After TAVR

Transcatheter aortic valve replacement (TAVR) represents an effective treatment to improve symptoms and prognosis in patients with symptomatic severe aortic stenosis (AS) (1-2)....

Sponsor: Niguarda HospitalEnrolling: 250012 locations
RECRUITINGNCT05779787

COronary Re-engageMent aFter randOm NavitoR alignmenT (COMFORT STUDY)

Whereas PCI before TAVR was previously recommended despite its uncertain prognostic role, recent data underline the possibility of a postponed coronary intervention using a...

Sponsor: Niguarda HospitalEnrolling: 1001 location
RECRUITINGNCT06557798

REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure

Transcatheter aortic valve implantation (TAVI) is a key-hole technique to replace an aortic heart valve that is narrowed and/or leaking. Although TAVI is a safe and effective...

Sponsor: The Leeds Teaching Hospitals NHS TrustEnrolling: 55020 locations
RECRUITINGPhase 3NCT06215378

Antagonization of Heparin With Protamine Sulfate After TAVI

Transcatheter aortic valve replacement (TAVR) is now the first therapeutic option offered to high and intermediate risk patients with symptomatic aortic stenosis but even to...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 9401 location
RECRUITINGNCT06818435

Portuguese Registry With Meril Myval THV Series - MyPORTuVal Registry

A prospective, single-arm, multi-centre registry to evaluate the safety and performance of Myval THV series using Transcatheter Aortic Valve Implantation (TAVI) procedure in...

Sponsor: Portuguese Association of Interventional CardiologyEnrolling: 1506 locations
RECRUITINGNCT06804148

MYVAL Transcatheter Heart Valve System - Prospective German Multicenter Registry

Rational of the Myval THV - Prospective German Multicenter Registry is to evaluate the performance of this relatively new but very promising TAVR valve in a consecutive real-word,...

Sponsor: Prof. Dr. med. Ingo EitelEnrolling: 20001 location
RECRUITINGNCT06817148

Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot Trial

The study protocol is a randomized trial of standard of care therapies for severe aortic stenosis (AS) in patients with a bicuspid aortic valve (BAV). Namely, the therapies to...

Sponsor: Cedars-Sinai Medical CenterEnrolling: 2501 location
RECRUITINGNCT03143361

Prospective European Multicenter Study on Aortic Valve Replacement: (E-AVR Registry)

Traditional and transcatheter surgical treatments of severe aortic valve stenosis (SAVS) are increasing in parallel with the improved life-expectancy. Recent randomized trials...

Sponsor: University of ParmaEnrolling: 80001 location
RECRUITINGNCT05572710

Avalus European Registry - an Observational Study to Evaluate Safety and Efficacy in a Real World Population

This is a prospective, observational, single-arm, multi-center registry of patients undergoing bioprosthetic aortic valve replacement with the Avalus valve. This prospective...

Sponsor: Universitaire Ziekenhuizen KU LeuvenEnrolling: 100019 locations
RECRUITINGNCT04889872

PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

This study objective is to establish the safety and effectiveness of the Edwards SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve systems in subjects...

Sponsor: Edwards LifesciencesEnrolling: 225020 locations
RECRUITINGNCT07520656

Impact of Transcatheter Aortic Valve Implantation and Mitral Valve Repair on Sleep-Disordered Breathing

This prospective observational study aims to investigate the impact of transcatheter aortic valve implantation (TAVI) and transcatheter mitral valve edge-to-edge repair (M-TEER)...

Sponsor: Aristides PlaitisEnrolling: 1501 location
RECRUITINGNCT03972644

Danish National Randomized Study on Early Aortic Valve Replacement in Patients With Asymptomatic Severe Aortic Stenosis

The purpose of this study is to examine the impact of early surgery in patients with asymptomatic severe aortic valve stenosis with signs of subclinical LV dysfunction despite...

Sponsor: Odense University HospitalEnrolling: 17001 location
RECRUITINGNCT05758662

The Effect of Subclinical Leaflet Thrombosis and Prosthesis Type on Transcatheter Aortic Valve Degeneration (POPular...

A multicentre cross-sectional cohort study to assess the difference in bioprosthetic micro-calcification activity, detected with 18F-NaF PET-CT, as early marker of transcatheter...

Sponsor: St. Antonius HospitalEnrolling: 1804 locations
RECRUITINGNCT05603026

MRI in Transcatheter Aortic Valve Replacement Patients

The hypothesis is that SEV result in superior valvular hemodynamics (more pronounced during exercise) and exercise capacity relative to BEV. Furthermore, the hypothesis is that...

Sponsor: University Hospitals Cleveland Medical CenterEnrolling: 901 location
RECRUITINGNCT05864456

Prizvalve Pro™ Transcatheter Aortic Valve Replacement Study

The purpose of this clinical trial is to evaluate the safety and efficacy of the Prizvalve Pro™ transcatheter aortic valve system in the treatment of patients with severe aortic...

Sponsor: Shanghai NewMed Medical Co., Ltd.Enrolling: 731 location
RECRUITINGNCT07477002

Post-Dilatation in Balloon-Expandable TAVI Prostheses

Asymmetrical and inadequate expansion of transcatheter heart valves (THVs) have been described as a key predictor of impaired valve hemodynamic performance predisposing patients...

Sponsor: Medical University of ViennaEnrolling: 1461 location

Frequently Asked Questions

There are currently 26 clinical trials for Aortic Valve Stenosis, with 26 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Aortic Valve Stenosis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 1 Phase 3 trials for Aortic Valve Stenosis, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.